Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
52.49
-0.78 (-1.46%)
At close: Jul 21, 2026, 4:00 PM EDT
52.77
+0.28 (0.53%)
After-hours: Jul 21, 2026, 7:34 PM EDT

Inspire Medical Systems Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $52.08. The average 1-year stock price forecast is 0.78% lower than the current stock price, while the lowest is $39 (-25.70%) and the highest is $65 (+23.83%).

Price Target: $52.08 (-0.78%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$39$52.08$54$65
Change-25.70%-0.78%+2.88%+23.83%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy444333
Buy111000
Hold121010111212
Sell000111
Strong Sell000000
Total171515151616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Hold
Maintains
$50$54
HoldMaintains$50$54+2.88%Jul 16, 2026
RBC Capital
RBC Capital
Hold
Maintains
$45
HoldMaintains$45-14.27%Jul 14, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$56
HoldMaintains$56+6.69%Jul 3, 2026
Freedom Capital Markets
Freedom Capital Markets
Buy
Initiates
$62
BuyInitiates$62+18.12%Jul 1, 2026
Evercore ISI
Evercore ISI
Hold
Downgrades
$55$40
HoldDowngrades$55$40-23.80%Jun 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
843.35M
from 911.98M
Decreased by -7.53%
Revenue Next Year
875.61M
from 843.35M
Increased by 3.83%
EPS This Year
0.90
from 2.42
Decreased by -62.68%
EPS Next Year
1.26
from 0.90
Increased by 39.81%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
233.39M407.86M624.80M802.80M911.98M843.35M
Revenue Growth
102.28%74.75%53.19%28.49%13.60%-7.53%
Gross Profit
200.12M341.74M528.22M679.82M778.76M725.67M
Gross Margin
85.74%83.79%84.54%84.68%85.39%86.05%
Operating Income
-39.85M-47.59M-40.27M36.08M50.95M20.85M
Net Income
-42.04M-44.88M-21.15M53.51M145.42M13.10M
EPS
----2.420.90
EPS Growth
----38.29%-62.68%
Forward PE
---114.3757.1458.11
Free Cash Flow
-10.69M17.43M27.63K62.72M54.50M119.60M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High852.4M
Avg843.3M
Low826.0M

Revenue Growth

Revenue Growth202620272028
High
-6.5%
Avg
-7.5%
Low
-9.4%

EPS Forecast

EPS202620272028
High1.00
Avg0.90
Low0.79

EPS Growth

EPS Growth202620272028
High
-58.7%
Avg
-62.7%
Low
-67.4%